Skip to main content

Table 1 Comparison of mean values of ages and clinical characteristics of participants in the three intervention groups

From: A short course of oral ranitidine as a novel treatment for toddler’s diarrhea: a parallel-group randomized controlled trial

Variables Oral ranitidine d
Mean ± SD
Probiotic b d
Mean ± SD
Placeboc d
Mean ± SD
F p-value
Age (months) 23.90 ± 9.41 17.70 ± 7.62 17.70 ± 4.11 3.016 0.061
Male/Female ratio 13/7 6/4 4/6   
Weight (kilogram) 12.85 ± 2.89 11.40 ± 1.37 13.30 ± 2.88 1.517 0.233
MUAC (centimeter) 15.25 ± 0.72 15.10 ± 0.84 15.70 ± 0.92 1.577 0.220
Height (centimeter) 90.73 ± 7.35 *86.30 ± 4.22 *85.70 ± 2.21 3.385 0.045
Pulse rate 102.40 ± 4.03 104.00 ± 3.13 103.80 ± 2.39 0.937 0.401
Temperaturea 36.92 ± 0.23 36.82 ± 0.23 36.92 ± 0.31 0.587 0.561
Respiratory rate *31.50 ± 3.36 *32.80 ± 2.53 34.60 ± 1.35 4.135 0.024
  1. *Duncan multiple comparison tests indicating means not significantly different. p value < 0.05 adopted as statistically significant
  2. aMeasured in degree centigrade b Lyophilized lactic acid bacteria c Vitamin C tablet
  3. SD standard deviation, MUAC mid-upper arm circumference
  4. dMean weight-for-age (W/A) for ranitidine, probiotic, and placebo groups were 11.98 kg, 10.95 kg and 10.95 kg respectively. Mean height-for-age (H/A) were 88.95 cm (ranitidine group), 85.85 cm (probiotic and placebo groups). Mean weight-for-height (W/H) Z scores were 0.013 for ranitidine group, 0.001 for probiotic group and 0.003 for placebo group